Alchemist Corporation Q3 FY26: Mounting Losses Signal Deepening Operational Crisis

Feb 07 2026 04:42 PM IST
share
Share Via
Alchemist Corporation Limited, the micro-cap commodity chemicals trader, reported a devastating Q3 FY26 performance with consolidated net losses widening dramatically to ₹0.82 crores from ₹0.05 crores in Q2 FY26—a staggering 1,540.00% quarter-on-quarter deterioration. The ₹14.00 crore market capitalisation company, which trades at ₹27.61 per share, saw its stock surge 4.98% post-results despite the alarming financial trajectory, underscoring the speculative nature of trading in this counter.
Alchemist Corporation Q3 FY26: Mounting Losses Signal Deepening Operational Crisis
Net Loss (Q3 FY26)
-₹0.82 Cr
QoQ: ▼ 1,540.00%
Revenue (Q3 FY26)
₹1.80 Cr
First revenue in quarters
Operating Margin
-43.89%
Severely negative
ROE (Latest)
0.88%
Extremely weak

The company, formerly known as Haryana Fibres Limited and rebranded in 2008, operates in fabric and metals trading with occasional gold jewellery exports. After reporting zero revenues for four consecutive quarters through Q2 FY26, the sudden appearance of ₹1.80 crores in Q3 FY26 sales was overshadowed by catastrophic cost structures that pushed operating margins into deeply negative territory at -43.89%.

Year-on-year comparisons paint an even grimmer picture, with Q3 FY26 losses expanding 2,633.33% compared to the ₹0.03 crore loss reported in Q3 FY25. The company's shareholder equity has collapsed from ₹15.87 crores in March 2024 to just ₹0.56 crores by March 2025, representing a wealth destruction of over 96% in a single fiscal year.

Financial Performance: A Collapse in Capital Efficiency

The Q3 FY26 financial statements reveal fundamental operational dysfunction. Despite generating ₹1.80 crores in revenue—the first sales recorded since Q4 FY25—the company incurred employee costs of ₹2.19 crores, exceeding total sales by 21.67%. This extraordinary cost-to-revenue ratio resulted in an operating loss (PBDIT excluding other income) of ₹0.79 crores and an operating margin of -43.89%.

Quarter Revenue (₹ Cr) Net Profit (₹ Cr) QoQ Change YoY Change
Dec'25 (Q3 FY26) 1.80 -0.82 ▼ 1,540.00% ▼ 2,633.33%
Sep'25 (Q2 FY26) 0.00 -0.05 -28.57% -37.50%
Jun'25 (Q1 FY26) 0.00 -0.07 -50.00% +75.00%
Mar'25 (Q4 FY25) 0.00 -0.13 +366.67% N/A
Dec'24 (Q3 FY25) 0.00 -0.03 -62.50% N/A
Sep'24 (Q2 FY25) 0.00 -0.08 +100.00% N/A
Jun'24 (Q1 FY25) 0.00 -0.04 N/A N/A

The profit before tax of -₹0.94 crores in Q3 FY26 reflects interest costs of ₹0.04 crores and depreciation of ₹0.11 crores. A modest tax credit of ₹0.12 crores (12.77% effective rate) partially offset the pre-tax loss, bringing the final net loss to ₹0.82 crores. The PAT margin stood at -45.56%, indicating that for every rupee of revenue, the company destroyed 45.56 paise of shareholder value.

The company's return on equity (ROE) of 0.88% ranks amongst the weakest in the commodity chemicals sector, signalling extremely poor capital efficiency. This pales in comparison to the industry average of approximately 5%, highlighting fundamental deficiencies in the business model's ability to generate returns on invested capital. The average ROCE over recent periods stands at -1.30%, confirming that the company destroys value rather than creates it.

Critical Operational Red Flags

Employee costs exceeding revenue: With ₹2.19 crores in employee expenses against ₹1.80 crores in sales, the company's cost structure is fundamentally unsustainable. This 121.67% employee cost-to-revenue ratio indicates severe operational inefficiency and raises questions about the viability of the current business model.

Shareholder equity erosion: The collapse from ₹15.87 crores to ₹0.56 crores in shareholder funds represents a 96.47% destruction of book value within one fiscal year, leaving the company with minimal financial cushion.

Balance Sheet Deterioration: Vanishing Assets

The balance sheet tells a story of systematic asset liquidation and capital erosion. Fixed assets, which stood at ₹14.76 crores in March 2024, have been completely written down to zero by March 2025. Investments declined from ₹1.61 crores to ₹0.02 crores, representing a 98.76% reduction. Current assets marginally decreased from ₹1.43 crores to ₹1.31 crores.

On the liabilities side, reserves and surplus swung from a positive ₹10.95 crores in March 2024 to a negative ₹4.36 crores by March 2025, a deterioration of ₹15.31 crores. This dramatic reversal reflects accumulated losses that have wiped out retained earnings and begun eroding share capital. Current liabilities fell from ₹1.94 crores to ₹0.76 crores, primarily due to reduced trade payables, which dropped from ₹0.16 crores to ₹0.05 crores.

The company carries no long-term debt as of March 2025, which ordinarily would be viewed as a strength. However, in this context, it likely reflects an inability to secure financing rather than prudent capital management. With a debt-to-equity ratio of 0.04 and negative net debt, the company operates with minimal leverage—not by choice, but by necessity given its deteriorating creditworthiness.

Peer Comparison: Trailing the Commodity Chemicals Sector

Alchemist Corporation's performance ranks at the bottom of its peer group across virtually every meaningful metric. The company's loss-making status prevents meaningful P/E ratio comparison, whilst its 0.88% ROE compares unfavourably to peers such as Sreechem Resins (15.53% ROE) and Link Pharma Chem (4.94% ROE).

Company P/E (TTM) P/BV ROE Debt/Equity
Alchemist Corp. NA (Loss Making) 0.86x 0.88% 0.04
Sreechem Resins NA (Loss Making) 1.26x 15.53% 0.15
Square Four Pro. NA (Loss Making) 0.84x 0.00% 0.07
Vivid Global 25.22x 0.97x 4.84% -0.13
Emmessar Biotech 62.58x 1.80x 0.00% -0.92
Link Pharma Chem NA (Loss Making) 0.97x 4.94% 0.50

The company's price-to-book value of 0.86x appears superficially attractive, trading at a 14% discount to book value. However, this metric is misleading given the rapid erosion of book value itself. With shareholder equity having collapsed to ₹0.56 crores, the absolute book value per share stands at just ₹1.13, and further deterioration appears inevitable given ongoing losses.

At a market capitalisation of ₹14.00 crores, Alchemist Corporation ranks fifth amongst its peer group, reflecting its micro-cap status and limited institutional interest. The company has zero FII, mutual fund, insurance, or other DII holdings, with 74.11% promoter ownership and 25.89% non-institutional retail participation.

Valuation Analysis: Value Trap, Not Value Opportunity

The company's valuation metrics paint a picture of a deeply distressed business trading at what appears to be low multiples, but in reality represents a classic value trap. With an EV/EBITDA of -14.16x and EV/EBIT of -13.23x, the negative multiples reflect ongoing losses rather than undervaluation. The EV/Sales ratio of 7.87x appears elevated given the sporadic and declining revenue generation.

Valuation Dashboard

P/E Ratio (TTM): NA (Loss Making)

Price to Book Value: 0.86x (14% discount to rapidly eroding book)

EV/EBITDA: -14.16x (negative due to losses)

Dividend Yield: NA (no dividends)

Overall Assessment: RISKY - Value trap with deteriorating fundamentals

The company's overall valuation grade of "RISKY" has fluctuated between "Risky" and "Does Not Qualify" over the past several months, most recently changing to "Risky" from "Does Not Qualify" on November 12, 2024. This instability in valuation classification reflects the company's volatile financial performance and uncertain business prospects.

Trading at ₹27.61—its 52-week high—the stock has surged 163.71% from its 52-week low of ₹10.47. This dramatic price appreciation appears disconnected from fundamental performance, suggesting speculative trading activity rather than value-based investing. The absence of institutional participation and extremely low trading volumes (just 86 shares traded on February 9, 2026) underscore the illiquid and speculative nature of this counter.

Shareholding Pattern: Stable but Uninformed Ownership

The shareholding pattern has remained completely static over the past five quarters, with promoter holding steady at 74.11% and non-institutional investors at 25.89%. Wallet Circle Technologies Limited holds the entire promoter stake, with zero pledging of shares—one of the few positive indicators in an otherwise concerning profile.

Quarter Promoter FII MF Insurance Non-Inst.
Dec'25 74.11% 0.00% 0.00% 0.00% 25.89%
Sep'25 74.11% 0.00% 0.00% 0.00% 25.89%
Jun'25 74.11% 0.00% 0.00% 0.00% 25.89%
Mar'25 74.11% 0.00% 0.00% 0.00% 25.89%
Dec'24 74.11% 0.00% 0.00% 0.00% 25.89%

The complete absence of institutional investors—zero FII, mutual fund, insurance, or DII holdings—represents a significant red flag. Sophisticated institutional investors conduct rigorous due diligence and typically avoid companies with deteriorating fundamentals, operational uncertainties, and governance concerns. Their wholesale absence from Alchemist Corporation's shareholder base speaks volumes about the company's investment merit.

The static nature of the shareholding pattern, with no quarter-on-quarter changes whatsoever, suggests a locked-in shareholder base with limited liquidity. This illiquidity is confirmed by the minimal trading volumes, creating significant execution risk for investors attempting to enter or exit positions.

Stock Performance: Speculative Surge Defies Fundamentals

Despite catastrophic financial performance, Alchemist Corporation's stock has delivered extraordinary returns across multiple timeframes, highlighting the disconnect between price action and fundamental value. The stock has generated a 312.09% return over five years, dramatically outperforming the Sensex's 63.78% gain by an alpha of 248.31 percentage points.

Period Stock Return Sensex Return Alpha
1 Day +4.98% +0.58% +4.40%
1 Week +4.98% +2.94% +2.04%
1 Month +4.98% +0.59% +4.39%
YTD (FY26) +15.72% -1.36% +17.08%
2 Years +45.70% +17.42% +28.28%
3 Years +79.75% +38.25% +41.50%
5 Years +312.09% +63.78% +248.31%

This extraordinary outperformance appears entirely divorced from operational reality. The company has generated zero revenue for extended periods, consistently reported losses, and witnessed a 96% erosion in shareholder equity. The stock's technical trend classification of "BULLISH" as of February 3, 2026, reflects momentum and sentiment rather than fundamental strength.

The stock trades above its 5-day moving average of ₹26.30 and 20-day moving average of ₹21.61, with MACD, RSI, Bollinger Bands, KST, and Dow Theory all flashing bullish signals. However, the On-Balance Volume (OBV) indicator shows "No Trend," suggesting that the price appreciation lacks strong volume support—a classic characteristic of speculative, low-liquidity counters.

"When a stock surges 312% over five years whilst destroying 96% of shareholder equity, you're witnessing speculation, not investing."

Investment Thesis: Multiple Disqualifying Factors

The company's overall quality grade of "DOES NOT QUALIFY" accurately reflects its fundamental shortcomings. With 5-year sales growth of 0.00%, 5-year EBIT growth of 0.00%, average EBIT to interest coverage of -0.23x, average ROCE of -1.30%, and average ROE of 0.00%, Alchemist Corporation fails to meet even the most basic criteria for quality investing.

The company's Mojo Score of 40/100 places it firmly in "SELL" territory, with the recommendation to "Consider selling" and "Look for exit opportunities." The financial trend classification of "FLAT" for Q3 FY26 understates the severity of the situation, given that losses expanded sixteen-fold quarter-on-quarter.

Limited Positives

  • No promoter pledging (74.11% stake unpledged)
  • Zero long-term debt reduces insolvency risk
  • Stock trading at 52-week high shows momentum
  • Technical indicators showing bullish signals
  • Small absolute loss amounts limit downside

Critical Risk Factors

  • Employee costs (₹2.19 Cr) exceed revenue (₹1.80 Cr) by 21.67%
  • Shareholder equity collapsed 96.47% to ₹0.56 Cr in one year
  • Operating margin of -43.89% indicates fundamental dysfunction
  • Zero institutional holdings signal lack of confidence
  • ROE of 0.88% vs peer average of ~5% shows capital inefficiency
  • Sporadic revenue generation with four consecutive zero-revenue quarters
  • Extremely low liquidity (86 shares traded daily)
  • Fixed assets written down to zero
  • Negative reserves and surplus of ₹4.36 Cr
  • No dividend history or visibility

Outlook: Monitoring Points for Potential Turnaround

Whilst the current situation appears dire, investors should monitor specific indicators that could signal either further deterioration or an unlikely turnaround. The company's ability to generate consistent revenue, control employee costs, and halt the erosion of shareholder equity will determine its survival prospects.

Positive Catalysts to Watch

  • Consistent quarterly revenue generation above ₹5 crores
  • Employee cost reduction to below 50% of revenue
  • Return to positive operating margins
  • Any institutional investor participation
  • Stabilisation of shareholder equity

Red Flags Requiring Immediate Exit

  • Further deterioration in shareholder equity below ₹0.25 Cr
  • Continued zero or minimal revenue quarters
  • Operating margins remaining below -30%
  • Any promoter stake reduction or pledging
  • Regulatory actions or compliance issues
  • Further asset write-downs or impairments

The Verdict: Avoid This Value Trap

STRONG SELL

Score: 40/100

For Fresh Investors: Completely avoid. The company exhibits multiple disqualifying factors including negative operating margins, collapsing shareholder equity, sporadic revenue generation, and zero institutional confidence. The recent stock price surge reflects speculation in an illiquid counter, not fundamental value creation. With employee costs exceeding revenue and a 96% erosion in book value, this represents a classic value trap where apparent cheapness masks terminal decline.

For Existing Holders: Exit at current levels. The 4.98% post-result bounce and 52-week high pricing provide a rare liquidity window to exit a deteriorating situation. The Q3 FY26 results confirm accelerating operational dysfunction rather than turnaround progress. With losses expanding sixteen-fold quarter-on-quarter and fundamental business viability in question, holding this position exposes investors to significant permanent capital loss risk.

Fair Value Estimate: ₹8.00-₹10.00 (71% downside risk from current ₹27.61), reflecting liquidation value of remaining assets and probability-weighted survival scenarios. Current pricing appears driven by speculation rather than intrinsic value.

Note: ROCE = (EBIT - Other income)/(Capital Employed - Cash - Current Investments)

⚠️ Investment Disclaimer

This article is for educational and informational purposes only and should not be construed as financial advice. Investors should conduct their own due diligence, consider their risk tolerance and investment objectives, and consult with a qualified financial advisor before making any investment decisions. The views expressed are based on publicly available information as of February 9, 2026, and are subject to change. Past performance is not indicative of future results. Investing in micro-cap stocks involves substantial risk of loss.

{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News